A new flu vaccine geared to older people is coming soon

Moderna is set to release the first mRNA-based flu vaccine, specifically tailored to protect older adults, ahead of the upcoming flu season. This development marks a significant advancement in vaccine technology, offering a new approach to flu prevention that could prove especially beneficial for elderly populations, which are more vulnerable to severe flu complications. The FDA approval signals a major step forward in public health, potentially reducing hospitalizations and deaths among the elderly and offering hope for more effective flu treatments in the future.